New criteria for pharmaceutical trade marks in Mexico

Daniel Sanchez and Victor Ramirez of Olivares report on new guidelines in Mexico that change the criteria for pharmaceutical trade marks during the prosecution of market authorisations
Unlock this article.
The content you are trying to view is exclusive to our subscribers.
To unlock this article: